Published on
May 23, 2024
- 11:00 GMT
Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offering which also features GLP-1 ...
Tirzepatide, a dual GIP and GLP-1 receptor agonist (GIP/GLP-1 RA), is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. The GLP-1 segment is an important class of drugs for multiple cardiometabolic diseases. GLP-1 …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
